Coast IRB suspends ops following GAO probe
Coast IRB, the company targeted in a recent undercover operation by the GAO, has suspended operations following a warning letter from the FDA.
Archives for April 14, 2009
PharmEng to make proposal under bankruptcy act
PharmEng has filed a notice of intent (NOI) to make a proposal under the Canadian Bankruptcy and Insolvency Act in an attempt to “regain the company's financial footing”.
US CMOs economy proof in the long term, says F&S
The US contract manufacturing sector is strong enough to bounce back from any short-term slow down caused by the credit crisis, according to a new report by Frost & Sullivan (F&S).
Sanofi beats Teva in Medley melee
Sanofi Aventis has confirmed it is buying Brazil’s Medley for $664m (€500m), to position it as the largest player in South America’s generics market.
ASEAN GMP audit sharing a step to EU-like single market
The Association of Southeast Asia Nations’ (ASEAN) member states will recognise each others GMP certificates as part of a programme intended to raise standards and eliminate trade barriers.
Orion signs drug discovery contract with Jubilant
Finnish drugmaker Orion has forged an agreement with India’s Jubilant Organosys in the area of contract drug discovery and development.
Asahi launches high-compactable MCC excipient
Asahi Kasei has added to its range of excipients through the launch of Ceolus UF-711, which it claims is the first high-compactable microcrystalline cellulose (MCC) that makes tablets smaller.
Levinson replaced as Genentech CEO by Roche employee
Art Levinson is to step down from his role as Genentech’s CEO but will play “an active role” at the company as part of Roche’s attempts to integrate and retain the biotech’s key staff.
Pfizer moves for Indian unit, following Novartis’ lead
Pfizer is the latest company to seek greater control of its Indian subsidiary, falling into step with Swiss drug major Novartis which made a similar move late last month.